Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
SAPHNELO Inf Konz 300 mg/2ml Durchstf
Drug
Saphnelo, Konzentrat zur Herstellung einer Infusionslösung
Systemischer Lupus erythematodes (SLE)
07.15.0. – immunosuppressants
HAM – Human medicine
KOINF – Concentrate for solution for infusion
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
8/31/2022
8/30/2027
Dosage strength
Saphnelo 300 mg/2 ml, Konzentrat zur Herstellung einer Infusionslösung
Systemischer Lupus erythematodes (SLE)
01
Z – approved
Package
7680685120014
No information made available
A/R – Authorised / referenced
1 vial(s)
001
Z – approved
Declaration
Component
300 mg anifrolumabum
histidinum
histidini hydrochloridum monohydricum
lysini hydrochloridum
trehalosum dihydricum
polysorbatum 80
aqua ad iniectabile
histidini hydrochloridum monohydricum
lysini hydrochloridum
trehalosum dihydricum
polysorbatum 80
aqua ad iniectabile
Spezialitätenliste***
SL
-
-
990.60
None
Yes
10%
No
Authorisation holder
7601001348622
AstraZeneca AG
Neuhofstrasse 34
6340 Baar (ZG)
Neuhofstrasse 34
6340 Baar (ZG)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.